CD19-BCMA Dual Nanobody Based CAR-T Cells for Patients With DSA

Clinical trial NCT07451236 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07451236
Sponsor: Chang Yingjun
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Transplantation Candidates With Hematological Diseases

Start date: 2026-03-18
Primary completion: 2027-06-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.